Johns Hopkins Medicine press release
According to the US Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million people living with HIV in the United States, and another 1.2 to 2.2 million who are at highest risk for infection and could benefit from the preventive measure known as HIV PrEP.
HIV viral load testing is used to diagnose HIV infection at its earliest stages, monitor the effectiveness of antiretroviral therapy (ART) in keeping the virus at undetectable levels, and assess if the virus has developed any resistance to ART.
However, one question about viral load testing has remained unanswered: Does knowing one’s HIV viral load test result increase the “linkage-to-care” rates for seeking ART for an active infection or PrEP if not infected, but at high risk?
In a study published in JAMA Network Open, researchers at Johns Hopkins Medicine and CDC report that the answer may be no.
Read the full press release here.
Source : Johns Hopkins Medicine
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.